-
Product Insights
![]()
Mobidiag Ltd Pipeline Insight and Competitive Landscape, 2023
Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag's Prove-it products include prove-it sepsis, prove-it bone and joint, and prove-it herpes for the detection and analysis of the microarrays. The company's target therapy areas comprise in vitro diagnostics, gastrointestinal infections and other...
-
Product Insights
![]()
Immunochemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Spot test kits intended generally for rapid diagnosis, with immediate results, through immuno assays. Some of the tests carried out using immunochemistry rapid test include rabies virus test, allergenic food proteins, and enteric infection. The immunochemistry rapid tests and POC pipeline market research report provides comprehensive information about the immunochemistry rapid tests and POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
![]()
COVID 19 point of care (POC) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
COVID-19 point of care (POC) tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. The COVID-19 POC tests pipeline products report provides comprehensive information about the COVID 19 point of care tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides information on the pipeline products...
-
Product Insights
![]()
COVID 19 point of care (POC) Tests – Medical Devices Pipeline Assessment, 2020
COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid tests and point of care tests for COVID-19. GlobalData's Medical Devices sector report, “COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Sector Analysis
![]()
Germany Infectious Disease Market Outlook to 2025
GlobalData’s “Germany Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Germany Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic...
-
Sector Analysis
![]()
China Infectious Disease Market Outlook to 2025
GlobalData’s “China Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the China Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B, and Hepatitis C Nucleic...
-
Sector Analysis
![]()
Asia-Pacific Infectious Disease Market Outlook to 2025
GlobalData’s “Asia - Pacific Infectious Disease Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Asia - Pacific Infectious Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Chlamydia Trachomatis Tests, Clostridium difficile Tests, Cytomegalovirus (CMV) Tests, Hepatitis Tests, Human Immunodeficiency Virus (HIV) Tests, Human Papilloma Virus (HPV) Tests, Human T-Lymphotropic Virus (HTLV) Tests, Multi-parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs, Multi-parameter HIV, Hepatitis B,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.